InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,720.00
(
0.45%
)
Dow Jones
39,387.76
(
0.85%
)
Brent Oil
84.24
(
0.34%
)
Bitcoin
63,014.36
(
-0.05%
)
Post# of 39
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

CPTMatt

Send PM Follow Ignore
Followers 91
Posts 11766
Boards Moderated 0
Alias Born 01/05/2004

CPTMatt

Re: None

Tuesday, 04/13/2010 9:38:53 AM

Tuesday, April 13, 2010 9:38:53 AM

Post# of 39
Penwest Pharmaceuticals Gains 3% on Settled Litigation with Barr Lab 04/13 08:23 AM



09:23 AM Eastern Daylight Time, 04/13/2010 (MidnightTrader) -- Endo Pharmaceuticals (ENDP:$23.29,00$-0.08,00-0.34%) and Penwest Pharmaceuticals (PPCO:$3.6705,$0.0605,1.68%) say they have settled litigation with Barr Laboratories, Inc. regarding the production and sale of generic formulations of Opana ER (oxymorphone hydrochloride) Extended Release Tablets CII.
Under the terms of the settlement, Endo and Penwest have agreed to grant Barr a license to sell a generic of Opana ER on or after Sept. 15, 2012, or earlier under certain circumstances.
Price: 3.72, Change: +0.11 , Percent Change: +3.05

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up